TDP-43 nuclear loss in FTD/ALS causes widespread alternative polyadenylation changes
Yi ZengiD, Anastasiia LovchykovaiD, Tetsuya AkiyamaiD, Chang LiuiD, Caiwei GuoiD, Vidhya Maheswari Jawahar, Odilia Sianto, Anna CalliariiD, Mercedes PrudencioiD, Dennis W. DicksoniD, Leonard PetrucelliiD, Aaron D. GitleriD
Abstract
In frontotemporal dementia and amyotrophic lateral sclerosis, the RNA-binding protein TDP-43 is depleted from the nucleus. TDP-43 loss leads to cryptic exon inclusion but a role in other RNA processing events remains unresolved. Here, we show that loss of TDP-43 causes widespread changes in alternative polyadenylation, impacting expression of disease-relevant genes (e.g., ELP1, NEFL, and TMEM106B) and providing evidence that alternative polyadenylation is a new facet of TDP-43 pathology.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- TDP-43 loss induces extensive cryptic polyadenylation in ALS/FTD
Sam Bryce-Smith, Anna‐Leigh Brown, … Pietro Fratta·bioRxiv·Jan 22, 2024
- TDP-43 dysregulation of polyadenylation site selection is a defining feature of RNA misprocessing in ALS/FTD and related disorders
Frederick J. Arnold, Ya Cui, … Albert R. La Spada·bioRxiv·Jan 22, 2024
- TDP-43 toxic gain of function links ALS, FTD and Alzheimers Disease through splicing dysregulation
Welmoed van Zuiden, Thea Deborah Meimoun, … Eran Hornstein·bioRxiv·Apr 20, 2025
- Loss of TDP-43 function drives cryptic circular RNAs in neurodegenerative diseases
Chengzhang Zhu, Zhiyan Zhao, … Shuying Sun·bioRxiv·Sep 20, 2026
- TDP-43 represses cryptic exon inclusion in FTD/ALS gene UNC13A
X. Rosa Ma, Mercedes Prudencio, … Aaron D. Gitler·NaturePeer-reviewed·Feb 23, 2022
- RNA-deficient TDP-43 causes loss of free nuclear TDP-43 by sequestration
Sean S. Keating, Adekunle T. Bademosi, … Adam K. Walker·bioRxiv·Sep 6, 2022